Wong et al. elucidated that skin PAD4 activity was increased by diabetes, and inhibiting NETosis by Cl-amidine (PAD4 inhibitor) and cleaving NETs with DNase I may improve wound healing and reduce NET-driven chronic inflammation in diabetes3,4. This evidence concerns the gene PADI4 and diabetes mellitus.